The effects of antiplatelet agents in the prevention of ventricular tachyarrhythmias during acute myocardial ischemia in rats

Japanese Heart Journal

Volumn 40, Issue 1, 1999, Pages 79-86

  Ahn, Young Keun ^a   Cho, Jeong Gwan ^a   Park, Woo Suck ^a   Kim, Nam Ho ^a   Kim, Joon Woo ^a   Kim, Sung Hee ^a   Cho, Jang Hyun ^a   Park, Joo Hyung ^a   Jeong, Myung Ho ^a   Park, Jong Chun ^a   Kang, Jung Chaee ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Antiplatelet agent; Ventricular arrhythmia

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

ANIMAL EXPERIMENT; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; INTRAVENOUS DRUG ADMINISTRATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MORTALITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; ST SEGMENT ELEVATION;

EID: 0032943606     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/jhj.40.79     Document Type: Article

References (31)

1. Lewis HD, Davis JW, Archibald DG. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of a Veterans Administration Cooperative Study. N Engl J Med 1983; 309: 396-403.
2. Cairns JA, Gent M, Singer J. Aspirin, sulfinpyrazone, or both in unstable angina: results of a Canadian multicenter trial. N EnglJ Med 1985; 313: 1369-75.
3. ISIS-2 (Second international study of infarct survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2: 349-60.
4. Ridker PM, Manson JE, BuringJE, Muller JE, Hennekens CH. Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians. Circulation 1990; 82: 897-902.
5. Ridker PM, Manson JE, Gazziano JM, Buring JE, Hennekens CH. Low-dose aspirin therapy for chronic stable angina: a randomized, placebo-controlled clinical trial. Ann Intern Med 1991 ; 114: 835-9.
6. Ridker PM, Manson JE, BuringJE, Goldhaber SZ, Hennekens CH. Clinical characteristics of nonfatal myocardial infarction among individuals on prophylactic low-dose aspirin therapy. Circulation 1991; 84: 708-11.
7. The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990; 336: 827-30.
8. Nyman I, Laarsson H, Wallentin L. Prevention of serious cardiac events by low-dose aspirin in patients with silent myocardial ischemia. The research group on instability in coronary artery disease in southeast Sweden. Lancet 1992; 340: 497-501.
9. Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Sweddish angina pectoris trial (SAPAT) group. Lancet 1992; 340: 1421-25.
10. Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. In Braunwald E, editor. Heart Disease, 5th ed. Philadelphia: WB Saunders Co, 1997: 742-79.
11. Liberthson RR, Nagel EL, Hirschman JC, Nussenfeld SR. Prehospital ventricular fibrillation: prognosis and follow-up course. N EnglJ Med. 1974; 291: 317-21.
12. Baum RS, Alvarez H, Cobb LA. Survival after resuscitation from out-of-hospital ventricular fibrillation. Circulation 1974; 50: 1231-5.
13. Myerburg RJ, Conde CA, Sung RJ, et al. Clinical, electrophysiologic, and hemodynamic profile of patients resuscitated from prehospital cardiac arrest. Am J Med 1980; 68: 12-4.
14. Goldstein JA, Butterfiled MC, Ohnishi Y, Shelton TJ, Corr PB. Arrhythmogenic influence of intracoronary thrombosis during acute myocardial ischemia. Circulation 1994; 90: 139-43.
15. Davies MJ, Thomas A. Thrombosis and acute coronary artery lesions in sudden cardiac ischemic death. N EnglJ Med 1984; 303: 897-902.
16. Crawford T, Dexter D, Teare RD. Coronary artery pathology in sudden death from myocardial ischemia: a comparison by age groups. Lancet 1961; 1: 181-5.
17. Scott RF, Briggs TS. Pathologic findings in pre-hospital deaths due to coronary atherosclerosis. Am J Cardiol. 1972; 29: 782-7.
18. Haerem JW. Mural platelet microthrombi and major acute lesions of main epicardial arteries in sudden coronary death. Atherosclerosis. 1974; 19: 529-41.
19. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/ or sudden death. Circulation 1985; 71: 699-708.
20. Haerem JW. Platelet aggregates and mural microthrombi in the early stages of acute, fatal coronary disease. Thromb Res 1974; 5: 243-9.
21. Davies MJ, Thomas AC, Knapman PA, Hangartner JR. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation. 1986; 73: 418-27.
22. El-Maraghi N, Genton E. The relevance of platelet and fibrin thromboembolism of the coronary microcirculation, with special reference to sudden cardiac death. Circulation 1980; 62: 936-44.
23. Puig-Perellada P, Planas JM. Action of selective inhibitor of thromboxane synthetase on experimental thrombosis induced by arachidonic acid in rabbits. Lancet 1977; 2: 40-51.
24. Coker SJ, Parratt JR, Ledingham IM, Zeitlin IJ. Thromboxane and prostacyclin release from ischemic myocardium in relation to arrhythmia. Nature 1981; 291: 323-4.
25. Folts JD, Crowell EB, Rowe GG. Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation 1976; 54: 365-70.
26. Elwood PC, Sweetman PM. Aspirin and secondary mortality after myocardial infarction. Circulation 1980; 62: 53-8.
27. Sherry S. The anturane reinfarction trial. Circulation 1980; 62: 73-8.
28. Wit AL, Janse MJ. Experimental models of ventricular tachycardia and fibrillation caused by ischemia and infarction. Circulation 1992; 85: I-32-I-42.
29. Flores NA, Davies RLI, Penny WJ, Sheridan DJ. Coronary microangiography in the guinea pig, rabbit and ferret. Int Cardiol 1984; 6: 459-471.
30. Opitz CF, Mitchell GF, Pfeffer MA, Pfeffer JM. Arrhythmias and death after coronary artery occlusion in the rat. Circulation 1995; 9: 253-261.
31. Moschos CB, Lahiri K, Peter A, Jesrani MU, Regan TJ. Effect of aspirin upon experimental coronary and non-coronary thrombosis and arrhythmia. Am Heart J 1972; 84: 525-530.